Your browser doesn't support javascript.
loading
Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS3/GPR174.
Shinjo, Yuji; Makide, Kumiko; Satoh, Keita; Fukami, Fumiya; Inoue, Asuka; Kano, Kuniyuki; Otani, Yuko; Ohwada, Tomohiko; Aoki, Junken.
Afiliação
  • Shinjo Y; Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Miyagi 980-8578, Japan.
  • Makide K; Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Miyagi 980-8578, Japan; PRESTO, Japan Science and Technology Corporation, 4-1-8, Saitama 332-0012, Japan.
  • Satoh K; Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Miyagi 980-8578, Japan.
  • Fukami F; Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Miyagi 980-8578, Japan.
  • Inoue A; Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Miyagi 980-8578, Japan; PRESTO, Japan Science and Technology Corporation, 4-1-8, Saitama 332-0012, Japan; PRIME, Japan Agency for Medical Research and Development, 1-7-1, Tokyo 100-0004, Japan; LEAP, Japan Agency for Medical Researc
  • Kano K; Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Miyagi 980-8578, Japan; LEAP, Japan Agency for Medical Research and Development, 1-7-1, Tokyo 100-0004, Japan; AMED-CREST, Japan Agency for Medical Research and Development, 1-7-1, Tokyo 100-0004, Japan.
  • Otani Y; Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1, Tokyo 113-0033, Japan.
  • Ohwada T; Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1, Tokyo 113-0033, Japan.
  • Aoki J; Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Miyagi 980-8578, Japan; LEAP, Japan Agency for Medical Research and Development, 1-7-1, Tokyo 100-0004, Japan; AMED-CREST, Japan Agency for Medical Research and Development, 1-7-1, Tokyo 100-0004, Japan. Electronic address: jaoki@m.
Biochem Biophys Res Commun ; 494(1-2): 332-338, 2017 12 09.
Article em En | MEDLINE | ID: mdl-29017923
ABSTRACT
Lysophosphatidylserine (LysoPS) has been shown to have lipid mediator-like actions to induce mast cell degranulation and suppress T lymphocyte proliferation. Recently, three G protein-coupled receptors (GPCRs), LPS1/GPR34, LPS2/P2Y10, and LPS3/GPR174, were found to react specifically with LysoPS, raising the possibility that LysoPS exerts its roles through these receptors. In this study, we show that LPS3 is expressed in various T cell subtypes and is involved in suppression of Interleukin-2 (IL-2) production in CD4 T cells. We found that LysoPS suppressed the IL-2 production from activated T cells at the mRNA and protein levels. In addition, LysoPS did not have such an effect on the splenocytes and CD4 T cells isolated from LPS3-deficient mice. In LPS3-deficient splenocytes and CD4 T cells, anti-CD3/anti-CD28-triggered IL-2 production is somewhat increased. Interestingly, LysoPS with various fatty acids was up-regulated upon T cell activation. The present study raised the possibility that LysoPS exerts its immunosuppressive roles by down-regulating IL-2 production through a LysoPS-LPS3 axis in T cells.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lisofosfolipídeos / Linfócitos T CD4-Positivos / Interleucina-2 / Receptores Purinérgicos P2 / Receptores Acoplados a Proteínas G / Receptores de Lisofosfolipídeos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lisofosfolipídeos / Linfócitos T CD4-Positivos / Interleucina-2 / Receptores Purinérgicos P2 / Receptores Acoplados a Proteínas G / Receptores de Lisofosfolipídeos Idioma: En Ano de publicação: 2017 Tipo de documento: Article